Molecule Holdings Inc.
Molecule Holdings Inc. (MLCL.CN) Stock Competitors & Peer Comparison
See (MLCL.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MLCL.CN | CA$0.01 | +0.00% | 488.9K | -0.13 | -CA$0.04 | N/A |
| CURA.CN | CA$5.22 | +9.21% | 4.1B | -6.07 | -CA$0.86 | N/A |
| BHC.TO | CA$7.92 | -3.41% | 2.9B | 22.00 | CA$0.36 | N/A |
| GTII.CN | CA$9.30 | -5.10% | 2.2B | 32.69 | CA$0.29 | N/A |
| VRNO.CN | CA$6.32 | +6.76% | 2.2B | -5.40 | -CA$1.17 | N/A |
| CURA.TO | CA$2.31 | -11.49% | 1.9B | -5.13 | -CA$0.45 | N/A |
| TRUL.CN | CA$7.28 | -0.27% | 1.4B | -6.77 | -CA$1.09 | N/A |
| CRON.TO | CA$2.88 | +1.77% | 1.1B | 15.16 | CA$0.19 | N/A |
| TLRY.TO | CA$0.85 | -3.41% | 935.5M | -0.25 | -CA$3.40 | N/A |
| TER.CN | CA$2.38 | -0.42% | 804.8M | -1.33 | -CA$1.79 | N/A |
Stock Comparison
MLCL.CN vs CURA.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CURA.CN trades at CA$5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CURA.CN's ROE of -0.25%. Regarding short-term risk, MLCL.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CURA.CN's competition here
MLCL.CN vs BHC.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BHC.TO has a market cap of 2.9B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BHC.TO trades at CA$7.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BHC.TO's P/E ratio is 22.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BHC.TO's ROE of -0.09%. Regarding short-term risk, MLCL.CN is less volatile compared to BHC.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check BHC.TO's competition here
MLCL.CN vs GTII.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, GTII.CN has a market cap of 2.2B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while GTII.CN trades at CA$9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas GTII.CN's P/E ratio is 32.69. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to GTII.CN's ROE of +0.03%. Regarding short-term risk, MLCL.CN is less volatile compared to GTII.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check GTII.CN's competition here
MLCL.CN vs VRNO.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, VRNO.CN has a market cap of 2.2B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while VRNO.CN trades at CA$6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas VRNO.CN's P/E ratio is -5.40. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to VRNO.CN's ROE of -0.10%. Regarding short-term risk, MLCL.CN is less volatile compared to VRNO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check VRNO.CN's competition here
MLCL.CN vs CURA.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CURA.TO has a market cap of 1.9B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CURA.TO trades at CA$2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CURA.TO's P/E ratio is -5.13. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CURA.TO's ROE of -0.25%. Regarding short-term risk, MLCL.CN is less volatile compared to CURA.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CURA.TO's competition here
MLCL.CN vs TRUL.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TRUL.CN has a market cap of 1.4B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TRUL.CN trades at CA$7.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TRUL.CN's P/E ratio is -6.77. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TRUL.CN's ROE of -0.13%. Regarding short-term risk, MLCL.CN is less volatile compared to TRUL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TRUL.CN's competition here
MLCL.CN vs CRON.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CRON.TO has a market cap of 1.1B. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CRON.TO trades at CA$2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CRON.TO's P/E ratio is 15.16. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CRON.TO's ROE of +0.05%. Regarding short-term risk, MLCL.CN is less volatile compared to CRON.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CRON.TO's competition here
MLCL.CN vs TLRY.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TLRY.TO has a market cap of 935.5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TLRY.TO trades at CA$0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TLRY.TO's P/E ratio is -0.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TLRY.TO's ROE of -0.78%. Regarding short-term risk, MLCL.CN is less volatile compared to TLRY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TLRY.TO's competition here
MLCL.CN vs TER.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TER.CN has a market cap of 804.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TER.CN trades at CA$2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TER.CN's P/E ratio is -1.33. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TER.CN's ROE of -0.33%. Regarding short-term risk, MLCL.CN is less volatile compared to TER.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TER.CN's competition here
MLCL.CN vs DHT-UN.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, DHT-UN.TO has a market cap of 795.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while DHT-UN.TO trades at CA$14.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas DHT-UN.TO's P/E ratio is 358.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to DHT-UN.TO's ROE of +0.00%. Regarding short-term risk, MLCL.CN is less volatile compared to DHT-UN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check DHT-UN.TO's competition here
MLCL.CN vs GUD.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, GUD.TO has a market cap of 626.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while GUD.TO trades at CA$6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas GUD.TO's P/E ratio is 62.90. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to GUD.TO's ROE of +0.01%. Regarding short-term risk, MLCL.CN is less volatile compared to GUD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check GUD.TO's competition here
MLCL.CN vs DHT-U.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, DHT-U.TO has a market cap of 568.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while DHT-U.TO trades at CA$10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas DHT-U.TO's P/E ratio is 341.67. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to DHT-U.TO's ROE of +0.00%. Regarding short-term risk, MLCL.CN and DHT-U.TO have similar daily volatility (0.00).Check DHT-U.TO's competition here
MLCL.CN vs VRNO.NE Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, VRNO.NE has a market cap of 395.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while VRNO.NE trades at CA$1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas VRNO.NE's P/E ratio is -0.80. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to VRNO.NE's ROE of -0.32%. Regarding short-term risk, MLCL.CN is less volatile compared to VRNO.NE. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check VRNO.NE's competition here
MLCL.CN vs CPH.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CPH.TO has a market cap of 329.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CPH.TO trades at CA$12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CPH.TO's P/E ratio is 25.70. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CPH.TO's ROE of +0.10%. Regarding short-term risk, MLCL.CN is less volatile compared to CPH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CPH.TO's competition here
MLCL.CN vs ACB.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, ACB.TO has a market cap of 326.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while ACB.TO trades at CA$5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas ACB.TO's P/E ratio is 19.37. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to ACB.TO's ROE of +0.00%. Regarding short-term risk, MLCL.CN is less volatile compared to ACB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check ACB.TO's competition here
MLCL.CN vs WEED.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, WEED.TO has a market cap of 323.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while WEED.TO trades at CA$1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas WEED.TO's P/E ratio is -0.26. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to WEED.TO's ROE of -1.13%. Regarding short-term risk, MLCL.CN is less volatile compared to WEED.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check WEED.TO's competition here
MLCL.CN vs CL.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CL.CN has a market cap of 314.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CL.CN trades at CA$0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CL.CN's P/E ratio is -2.82. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CL.CN's ROE of -0.16%. Regarding short-term risk, MLCL.CN is less volatile compared to CL.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CL.CN's competition here
MLCL.CN vs OGI.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, OGI.TO has a market cap of 257.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while OGI.TO trades at CA$1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas OGI.TO's P/E ratio is 10.67. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to OGI.TO's ROE of +0.05%. Regarding short-term risk, MLCL.CN is less volatile compared to OGI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check OGI.TO's competition here
MLCL.CN vs CCHW.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CCHW.CN has a market cap of 228.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CCHW.CN trades at CA$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CCHW.CN's P/E ratio is -0.41. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CCHW.CN's ROE of -1.08%. Regarding short-term risk, MLCL.CN and CCHW.CN have similar daily volatility (0.00).Check CCHW.CN's competition here
MLCL.CN vs TSND.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TSND.TO has a market cap of 202M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TSND.TO trades at CA$0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TSND.TO's P/E ratio is 66.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TSND.TO's ROE of -0.33%. Regarding short-term risk, MLCL.CN is less volatile compared to TSND.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TSND.TO's competition here
MLCL.CN vs TH.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TH.TO has a market cap of 200.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TH.TO trades at CA$4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TH.TO's P/E ratio is -16.81. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TH.TO's ROE of +0.38%. Regarding short-term risk, MLCL.CN is less volatile compared to TH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TH.TO's competition here
MLCL.CN vs XLY.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, XLY.TO has a market cap of 200.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while XLY.TO trades at CA$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas XLY.TO's P/E ratio is 5.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to XLY.TO's ROE of +0.19%. Regarding short-term risk, MLCL.CN is less volatile compared to XLY.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check XLY.TO's competition here
MLCL.CN vs JUSH.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, JUSH.CN has a market cap of 169.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while JUSH.CN trades at CA$0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas JUSH.CN's P/E ratio is -2.53. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to JUSH.CN's ROE of +1.06%. Regarding short-term risk, MLCL.CN is less volatile compared to JUSH.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check JUSH.CN's competition here
MLCL.CN vs HLS.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, HLS.TO has a market cap of 157.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while HLS.TO trades at CA$5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas HLS.TO's P/E ratio is -6.34. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to HLS.TO's ROE of -0.24%. Regarding short-term risk, MLCL.CN is less volatile compared to HLS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check HLS.TO's competition here
MLCL.CN vs BHSC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BHSC.CN has a market cap of 137.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BHSC.CN trades at CA$7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BHSC.CN's P/E ratio is -4.37. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BHSC.CN's ROE of -5.75%. Regarding short-term risk, MLCL.CN is less volatile compared to BHSC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check BHSC.CN's competition here
MLCL.CN vs GRIN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, GRIN.CN has a market cap of 133.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while GRIN.CN trades at CA$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas GRIN.CN's P/E ratio is -13.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to GRIN.CN's ROE of -0.89%. Regarding short-term risk, MLCL.CN is less volatile compared to GRIN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check GRIN.CN's competition here
MLCL.CN vs CRDL.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CRDL.TO has a market cap of 122.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CRDL.TO trades at CA$1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CRDL.TO's P/E ratio is -3.15. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CRDL.TO's ROE of -2.10%. Regarding short-term risk, MLCL.CN is less volatile compared to CRDL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CRDL.TO's competition here
MLCL.CN vs PLTH.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, PLTH.CN has a market cap of 97.6M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while PLTH.CN trades at CA$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas PLTH.CN's P/E ratio is -1.58. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to PLTH.CN's ROE of -0.33%. Regarding short-term risk, MLCL.CN and PLTH.CN have similar daily volatility (0.00).Check PLTH.CN's competition here
MLCL.CN vs BNXT.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BNXT.CN has a market cap of 94.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BNXT.CN trades at CA$0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BNXT.CN's P/E ratio is -13.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BNXT.CN's ROE of +0.79%. Regarding short-term risk, MLCL.CN is less volatile compared to BNXT.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check BNXT.CN's competition here
MLCL.CN vs GDNS.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, GDNS.CN has a market cap of 91M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while GDNS.CN trades at CA$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas GDNS.CN's P/E ratio is -2.74. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to GDNS.CN's ROE of -1.54%. Regarding short-term risk, MLCL.CN and GDNS.CN have similar daily volatility (0.00).Check GDNS.CN's competition here
MLCL.CN vs MDP.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MDP.TO has a market cap of 88.4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MDP.TO trades at CA$2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MDP.TO's P/E ratio is 24.91. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MDP.TO's ROE of +0.06%. Regarding short-term risk, MLCL.CN is less volatile compared to MDP.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check MDP.TO's competition here
MLCL.CN vs INNO.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, INNO.CN has a market cap of 67.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while INNO.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas INNO.CN's P/E ratio is -23.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to INNO.CN's ROE of -0.13%. Regarding short-term risk, MLCL.CN is less volatile compared to INNO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check INNO.CN's competition here
MLCL.CN vs CBST.NE Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CBST.NE has a market cap of 63.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CBST.NE trades at CA$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CBST.NE's P/E ratio is -0.43. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CBST.NE's ROE of +10.11%. Regarding short-term risk, MLCL.CN is less volatile compared to CBST.NE. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CBST.NE's competition here
MLCL.CN vs VEXT.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, VEXT.CN has a market cap of 63.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while VEXT.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas VEXT.CN's P/E ratio is -2.81. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to VEXT.CN's ROE of -0.24%. Regarding short-term risk, MLCL.CN is less volatile compared to VEXT.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check VEXT.CN's competition here
MLCL.CN vs TGOD.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TGOD.CN has a market cap of 62.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TGOD.CN trades at CA$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TGOD.CN's P/E ratio is -3.28. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TGOD.CN's ROE of -0.90%. Regarding short-term risk, MLCL.CN and TGOD.CN have similar daily volatility (0.00).Check TGOD.CN's competition here
MLCL.CN vs MRMD.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MRMD.CN has a market cap of 58.4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MRMD.CN trades at CA$0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MRMD.CN's P/E ratio is -2.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MRMD.CN's ROE of -0.25%. Regarding short-term risk, MLCL.CN is less volatile compared to MRMD.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check MRMD.CN's competition here
MLCL.CN vs STEM.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, STEM.CN has a market cap of 53.6M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while STEM.CN trades at CA$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas STEM.CN's P/E ratio is -0.11. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to STEM.CN's ROE of -2.75%. Regarding short-term risk, MLCL.CN and STEM.CN have similar daily volatility (0.00).Check STEM.CN's competition here
MLCL.CN vs CXXI.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CXXI.CN has a market cap of 47.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CXXI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CXXI.CN's P/E ratio is -10.12. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CXXI.CN's ROE of -0.13%. Regarding short-term risk, MLCL.CN is less volatile compared to CXXI.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CXXI.CN's competition here
MLCL.CN vs HEXO.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, HEXO.TO has a market cap of 38.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while HEXO.TO trades at CA$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas HEXO.TO's P/E ratio is -0.26. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to HEXO.TO's ROE of -2.06%. Regarding short-term risk, MLCL.CN is less volatile compared to HEXO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check HEXO.TO's competition here
MLCL.CN vs CHM.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CHM.CN has a market cap of 37.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CHM.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CHM.CN's P/E ratio is -5.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CHM.CN's ROE of +0.07%. Regarding short-term risk, MLCL.CN and CHM.CN have similar daily volatility (0.00).Check CHM.CN's competition here
MLCL.CN vs IAN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, IAN.CN has a market cap of 33.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while IAN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas IAN.CN's P/E ratio is -0.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to IAN.CN's ROE of -0.15%. Regarding short-term risk, MLCL.CN and IAN.CN have similar daily volatility (0.00).Check IAN.CN's competition here
MLCL.CN vs AVCN.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AVCN.TO has a market cap of 32M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AVCN.TO trades at CA$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AVCN.TO's P/E ratio is -9.33. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AVCN.TO's ROE of -3.82%. Regarding short-term risk, MLCL.CN is less volatile compared to AVCN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check AVCN.TO's competition here
MLCL.CN vs EPIC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, EPIC.CN has a market cap of 31.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while EPIC.CN trades at CA$0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas EPIC.CN's P/E ratio is 13.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to EPIC.CN's ROE of +0.06%. Regarding short-term risk, MLCL.CN and EPIC.CN have similar daily volatility (0.00).Check EPIC.CN's competition here
MLCL.CN vs GWAY.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, GWAY.CN has a market cap of 30.4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while GWAY.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas GWAY.CN's P/E ratio is -11.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to GWAY.CN's ROE of -0.20%. Regarding short-term risk, MLCL.CN is less volatile compared to GWAY.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check GWAY.CN's competition here
MLCL.CN vs LABS.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, LABS.TO has a market cap of 29.5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while LABS.TO trades at CA$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas LABS.TO's P/E ratio is -3.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to LABS.TO's ROE of -0.17%. Regarding short-term risk, MLCL.CN is less volatile compared to LABS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check LABS.TO's competition here
MLCL.CN vs MMEN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MMEN.CN has a market cap of 27.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MMEN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MMEN.CN's P/E ratio is -0.13. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MMEN.CN's ROE of -0.96%. Regarding short-term risk, MLCL.CN is less volatile compared to MMEN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check MMEN.CN's competition here
MLCL.CN vs YOUR.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, YOUR.CN has a market cap of 22.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while YOUR.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas YOUR.CN's P/E ratio is 8.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to YOUR.CN's ROE of -1.18%. Regarding short-term risk, MLCL.CN and YOUR.CN have similar daily volatility (0.00).Check YOUR.CN's competition here
MLCL.CN vs VIN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, VIN.CN has a market cap of 20.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while VIN.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas VIN.CN's P/E ratio is -0.67. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to VIN.CN's ROE of -0.79%. Regarding short-term risk, Volatility data is not available for a full comparison. MLCL.CN has daily volatility of 0.00 and VIN.CN has daily volatility of N/A.Check VIN.CN's competition here
MLCL.CN vs CWEB.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CWEB.TO has a market cap of 19M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CWEB.TO trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CWEB.TO's P/E ratio is -0.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CWEB.TO's ROE of -0.93%. Regarding short-term risk, MLCL.CN is less volatile compared to CWEB.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CWEB.TO's competition here
MLCL.CN vs AYR-A.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AYR-A.CN has a market cap of 18.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AYR-A.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AYR-A.CN's P/E ratio is -0.03. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AYR-A.CN's ROE of -0.68%. Regarding short-term risk, MLCL.CN is less volatile compared to AYR-A.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check AYR-A.CN's competition here
MLCL.CN vs IMCC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, IMCC.CN has a market cap of 17.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while IMCC.CN trades at CA$5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas IMCC.CN's P/E ratio is -2.68. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to IMCC.CN's ROE of -1.52%. Regarding short-term risk, MLCL.CN is less volatile compared to IMCC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check IMCC.CN's competition here
MLCL.CN vs RWB.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, RWB.CN has a market cap of 16.5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while RWB.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas RWB.CN's P/E ratio is -0.13. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to RWB.CN's ROE of +0.87%. Regarding short-term risk, MLCL.CN and RWB.CN have similar daily volatility (0.00).Check RWB.CN's competition here
MLCL.CN vs TRIP.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TRIP.CN has a market cap of 16M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TRIP.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TRIP.CN's P/E ratio is -2.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TRIP.CN's ROE of -0.33%. Regarding short-term risk, MLCL.CN is less volatile compared to TRIP.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TRIP.CN's competition here
MLCL.CN vs MRV.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MRV.TO has a market cap of 15.4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MRV.TO trades at CA$1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MRV.TO's P/E ratio is -19.29. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MRV.TO's ROE of N/A. Regarding short-term risk, MLCL.CN is less volatile compared to MRV.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check MRV.TO's competition here
MLCL.CN vs EXM.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, EXM.CN has a market cap of 15.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while EXM.CN trades at CA$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas EXM.CN's P/E ratio is -0.91. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to EXM.CN's ROE of -18.63%. Regarding short-term risk, MLCL.CN and EXM.CN have similar daily volatility (0.00).Check EXM.CN's competition here
MLCL.CN vs CHAL.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CHAL.CN has a market cap of 14.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CHAL.CN trades at CA$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CHAL.CN's P/E ratio is -2.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CHAL.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and CHAL.CN have similar daily volatility (0.00).Check CHAL.CN's competition here
MLCL.CN vs RIV.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, RIV.CN has a market cap of 13.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while RIV.CN trades at CA$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas RIV.CN's P/E ratio is -0.21. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to RIV.CN's ROE of -0.49%. Regarding short-term risk, MLCL.CN and RIV.CN have similar daily volatility (0.00).Check RIV.CN's competition here
MLCL.CN vs ORI.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, ORI.CN has a market cap of 11.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while ORI.CN trades at CA$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas ORI.CN's P/E ratio is -2.11. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to ORI.CN's ROE of +0.51%. Regarding short-term risk, MLCL.CN and ORI.CN have similar daily volatility (0.00).Check ORI.CN's competition here
MLCL.CN vs CLC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CLC.CN has a market cap of 11.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CLC.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CLC.CN's P/E ratio is 4.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CLC.CN's ROE of +0.11%. Regarding short-term risk, MLCL.CN and CLC.CN have similar daily volatility (0.00).Check CLC.CN's competition here
MLCL.CN vs CTX.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CTX.TO has a market cap of 10.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CTX.TO trades at CA$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CTX.TO's P/E ratio is -3.37. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CTX.TO's ROE of -0.19%. Regarding short-term risk, MLCL.CN is less volatile compared to CTX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CTX.TO's competition here
MLCL.CN vs CNFA.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CNFA.CN has a market cap of 9.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CNFA.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CNFA.CN's P/E ratio is -0.83. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CNFA.CN's ROE of -7.84%. Regarding short-term risk, MLCL.CN and CNFA.CN have similar daily volatility (0.00).Check CNFA.CN's competition here
MLCL.CN vs VIVO.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, VIVO.TO has a market cap of 9.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while VIVO.TO trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas VIVO.TO's P/E ratio is -0.16. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to VIVO.TO's ROE of -0.78%. Regarding short-term risk, MLCL.CN is less volatile compared to VIVO.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check VIVO.TO's competition here
MLCL.CN vs OILS.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, OILS.CN has a market cap of 9.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while OILS.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas OILS.CN's P/E ratio is 5.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to OILS.CN's ROE of +0.06%. Regarding short-term risk, MLCL.CN and OILS.CN have similar daily volatility (0.00).Check OILS.CN's competition here
MLCL.CN vs PWR.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, PWR.CN has a market cap of 8.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while PWR.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas PWR.CN's P/E ratio is -1.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to PWR.CN's ROE of -0.90%. Regarding short-term risk, MLCL.CN is less volatile compared to PWR.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check PWR.CN's competition here
MLCL.CN vs LOBE.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, LOBE.CN has a market cap of 8.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while LOBE.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas LOBE.CN's P/E ratio is -1.12. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to LOBE.CN's ROE of +1.67%. Regarding short-term risk, MLCL.CN and LOBE.CN have similar daily volatility (0.00).Check LOBE.CN's competition here
MLCL.CN vs RVV.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, RVV.CN has a market cap of 8.4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while RVV.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas RVV.CN's P/E ratio is -2.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to RVV.CN's ROE of -0.61%. Regarding short-term risk, MLCL.CN is less volatile compared to RVV.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check RVV.CN's competition here
MLCL.CN vs CLSH.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CLSH.CN has a market cap of 8.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CLSH.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CLSH.CN's P/E ratio is 3.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CLSH.CN's ROE of -0.04%. Regarding short-term risk, MLCL.CN and CLSH.CN have similar daily volatility (0.00).Check CLSH.CN's competition here
MLCL.CN vs AH.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AH.TO has a market cap of 8.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AH.TO trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AH.TO's P/E ratio is -0.22. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AH.TO's ROE of -0.58%. Regarding short-term risk, MLCL.CN is less volatile compared to AH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check AH.TO's competition here
MLCL.CN vs AUSA.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AUSA.CN has a market cap of 7.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AUSA.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AUSA.CN's P/E ratio is -0.11. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AUSA.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and AUSA.CN have similar daily volatility (0.00).Check AUSA.CN's competition here
MLCL.CN vs STHZ.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, STHZ.CN has a market cap of 7.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while STHZ.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas STHZ.CN's P/E ratio is -0.10. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to STHZ.CN's ROE of +0.10%. Regarding short-term risk, MLCL.CN and STHZ.CN have similar daily volatility (0.00).Check STHZ.CN's competition here
MLCL.CN vs MOJO.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MOJO.CN has a market cap of 7.5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MOJO.CN trades at CA$0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MOJO.CN's P/E ratio is -5.36. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MOJO.CN's ROE of -11.49%. Regarding short-term risk, MLCL.CN and MOJO.CN have similar daily volatility (0.00).Check MOJO.CN's competition here
MLCL.CN vs SPR.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, SPR.CN has a market cap of 7.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while SPR.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas SPR.CN's P/E ratio is -0.40. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to SPR.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and SPR.CN have similar daily volatility (0.00).Check SPR.CN's competition here
MLCL.CN vs AVNT.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AVNT.TO has a market cap of 7.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AVNT.TO trades at CA$0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AVNT.TO's P/E ratio is -0.32. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AVNT.TO's ROE of -0.60%. Regarding short-term risk, MLCL.CN and AVNT.TO have similar daily volatility (0.00).Check AVNT.TO's competition here
MLCL.CN vs MVMD.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MVMD.CN has a market cap of 7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MVMD.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MVMD.CN's P/E ratio is -1.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MVMD.CN's ROE of -0.47%. Regarding short-term risk, MLCL.CN and MVMD.CN have similar daily volatility (0.00).Check MVMD.CN's competition here
MLCL.CN vs CDVA.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CDVA.CN has a market cap of 6.6M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CDVA.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CDVA.CN's P/E ratio is -6.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CDVA.CN's ROE of +0.26%. Regarding short-term risk, MLCL.CN is less volatile compared to CDVA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CDVA.CN's competition here
MLCL.CN vs SE.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, SE.CN has a market cap of 6.6M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while SE.CN trades at CA$0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas SE.CN's P/E ratio is 2.43. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to SE.CN's ROE of -0.02%. Regarding short-term risk, MLCL.CN and SE.CN have similar daily volatility (0.00).Check SE.CN's competition here
MLCL.CN vs SNN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, SNN.CN has a market cap of 6.1M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while SNN.CN trades at CA$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas SNN.CN's P/E ratio is -0.15. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to SNN.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and SNN.CN have similar daily volatility (0.00).Check SNN.CN's competition here
MLCL.CN vs WLLW.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, WLLW.TO has a market cap of 5.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while WLLW.TO trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas WLLW.TO's P/E ratio is -0.22. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to WLLW.TO's ROE of +15.73%. Regarding short-term risk, MLCL.CN is less volatile compared to WLLW.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check WLLW.TO's competition here
MLCL.CN vs BCBC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BCBC.CN has a market cap of 5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BCBC.CN trades at CA$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BCBC.CN's P/E ratio is -2.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BCBC.CN's ROE of -4.27%. Regarding short-term risk, MLCL.CN is less volatile compared to BCBC.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check BCBC.CN's competition here
MLCL.CN vs BBM.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BBM.CN has a market cap of 5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BBM.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BBM.CN's P/E ratio is -1.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BBM.CN's ROE of -1.43%. Regarding short-term risk, MLCL.CN and BBM.CN have similar daily volatility (0.00).Check BBM.CN's competition here
MLCL.CN vs AYUR.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AYUR.CN has a market cap of 4.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AYUR.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AYUR.CN's P/E ratio is -1.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AYUR.CN's ROE of -3.52%. Regarding short-term risk, MLCL.CN and AYUR.CN have similar daily volatility (0.00).Check AYUR.CN's competition here
MLCL.CN vs AION.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AION.CN has a market cap of 4.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AION.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AION.CN's P/E ratio is -0.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AION.CN's ROE of +1.59%. Regarding short-term risk, MLCL.CN and AION.CN have similar daily volatility (0.00).Check AION.CN's competition here
MLCL.CN vs CANN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CANN.CN has a market cap of 4.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CANN.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CANN.CN's P/E ratio is -0.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CANN.CN's ROE of -0.66%. Regarding short-term risk, MLCL.CN and CANN.CN have similar daily volatility (0.00).Check CANN.CN's competition here
MLCL.CN vs BHNG.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BHNG.CN has a market cap of 4.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BHNG.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BHNG.CN's P/E ratio is -1.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BHNG.CN's ROE of +4.01%. Regarding short-term risk, MLCL.CN and BHNG.CN have similar daily volatility (0.00).Check BHNG.CN's competition here
MLCL.CN vs FFNT.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, FFNT.CN has a market cap of 4.6M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while FFNT.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas FFNT.CN's P/E ratio is -0.03. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to FFNT.CN's ROE of +0.79%. Regarding short-term risk, MLCL.CN and FFNT.CN have similar daily volatility (0.00).Check FFNT.CN's competition here
MLCL.CN vs LUFF.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, LUFF.CN has a market cap of 4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while LUFF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas LUFF.CN's P/E ratio is -0.56. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to LUFF.CN's ROE of -0.32%. Regarding short-term risk, Volatility data is not available for a full comparison. MLCL.CN has daily volatility of 0.00 and LUFF.CN has daily volatility of N/A.Check LUFF.CN's competition here
MLCL.CN vs FH.NE Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, FH.NE has a market cap of 3.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while FH.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas FH.NE's P/E ratio is -0.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to FH.NE's ROE of -2.14%. Regarding short-term risk, MLCL.CN is less volatile compared to FH.NE. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check FH.NE's competition here
MLCL.CN vs TILT.NE Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TILT.NE has a market cap of 3.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TILT.NE trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TILT.NE's P/E ratio is -0.03. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TILT.NE's ROE of +6.23%. Regarding short-term risk, MLCL.CN is less volatile compared to TILT.NE. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check TILT.NE's competition here
MLCL.CN vs BAMM.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, BAMM.CN has a market cap of 3.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while BAMM.CN trades at CA$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas BAMM.CN's P/E ratio is -0.12. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to BAMM.CN's ROE of +0.24%. Regarding short-term risk, MLCL.CN and BAMM.CN have similar daily volatility (0.00).Check BAMM.CN's competition here
MLCL.CN vs RMC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, RMC.CN has a market cap of 3.4M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while RMC.CN trades at CA$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas RMC.CN's P/E ratio is -4.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to RMC.CN's ROE of +1.25%. Regarding short-term risk, MLCL.CN and RMC.CN have similar daily volatility (0.00).Check RMC.CN's competition here
MLCL.CN vs THC.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, THC.CN has a market cap of 3.3M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while THC.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas THC.CN's P/E ratio is -1.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to THC.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and THC.CN have similar daily volatility (0.00).Check THC.CN's competition here
MLCL.CN vs NBUD.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, NBUD.CN has a market cap of 3.2M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while NBUD.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas NBUD.CN's P/E ratio is -1.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to NBUD.CN's ROE of -0.54%. Regarding short-term risk, MLCL.CN and NBUD.CN have similar daily volatility (0.00).Check NBUD.CN's competition here
MLCL.CN vs MSVN.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, MSVN.CN has a market cap of 2.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while MSVN.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas MSVN.CN's P/E ratio is -0.06. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to MSVN.CN's ROE of +19.42%. Regarding short-term risk, MLCL.CN and MSVN.CN have similar daily volatility (0.00).Check MSVN.CN's competition here
MLCL.CN vs AREV.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, AREV.CN has a market cap of 2.9M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while AREV.CN trades at CA$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas AREV.CN's P/E ratio is -2.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to AREV.CN's ROE of +2.76%. Regarding short-term risk, MLCL.CN and AREV.CN have similar daily volatility (0.00).Check AREV.CN's competition here
MLCL.CN vs ASP.TO Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, ASP.TO has a market cap of 2.8M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while ASP.TO trades at CA$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas ASP.TO's P/E ratio is -0.08. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to ASP.TO's ROE of +3.10%. Regarding short-term risk, MLCL.CN and ASP.TO have similar daily volatility (0.00).Check ASP.TO's competition here
MLCL.CN vs CVGR.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CVGR.CN has a market cap of 2.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CVGR.CN trades at CA$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CVGR.CN's P/E ratio is -6.00. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CVGR.CN's ROE of +0.20%. Regarding short-term risk, MLCL.CN is less volatile compared to CVGR.CN. This indicates potentially lower risk in terms of short-term price fluctuations for MLCL.CN.Check CVGR.CN's competition here
MLCL.CN vs CFT.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, CFT.CN has a market cap of 2.7M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while CFT.CN trades at CA$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas CFT.CN's P/E ratio is -0.13. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to CFT.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and CFT.CN have similar daily volatility (0.00).Check CFT.CN's competition here
MLCL.CN vs IPOT.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, IPOT.CN has a market cap of 2.6M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while IPOT.CN trades at CA$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas IPOT.CN's P/E ratio is -0.50. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to IPOT.CN's ROE of +0.00%. Regarding short-term risk, MLCL.CN and IPOT.CN have similar daily volatility (0.00).Check IPOT.CN's competition here
MLCL.CN vs TGIF.CN Comparison August 2025
MLCL.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MLCL.CN stands at 488.9K. In comparison, TGIF.CN has a market cap of 2.5M. Regarding current trading prices, MLCL.CN is priced at CA$0.01, while TGIF.CN trades at CA$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MLCL.CN currently has a P/E ratio of -0.13, whereas TGIF.CN's P/E ratio is -0.25. In terms of profitability, MLCL.CN's ROE is +2.97%, compared to TGIF.CN's ROE of +0.13%. Regarding short-term risk, MLCL.CN and TGIF.CN have similar daily volatility (0.00).Check TGIF.CN's competition here